Home →Chemicals→Pharma Intermediates
Chemicals Division

Pharma Intermediates

API synthesis intermediates, USP/EP grade chemicals, and excipients from WHO-GMP certified manufacturers. Serving Indian and international pharmaceutical manufacturers.

Request Quotation science

India's API industry, with a market size of $15–16 billion, is entering a period of steady expansion at 7% CAGR. Indian pharma intermediates are essential components in API manufacturing, enabling production of various drug formulations for both domestic and global markets — and PLI scheme incentives are accelerating capacity expansion.

Product Categories

Pharmaceutical Intermediate Categories

Category Type / Grade Therapeutic Application Regulatory Standard
Bulk Drug Intermediates Large-volume, multi-step synthesis General pharmaceutical manufacturing — antibiotics, analgesics, antidiabetics USP / BP / IP
Custom Intermediates Tailored for specific API routes Specialised drug synthesis requiring unique chemical building blocks ICH Q7 / Q11
High-Potent APIs (HPAPIs) Highly active, low therapeutic dose Oncology (cytotoxics), hormonal therapies, CNS actives, targeted therapies WHO-GMP / EMA
Chiral Intermediates Enantiomerically pure compounds Cardiovascular, CNS, anti-infective drugs requiring stereochemical purity USP / EP
Reagent-Grade Chemicals High-purity analytical grade QC laboratories, method development, reference standard preparation ACS / HPLC Grade
Excipients Inactive formulation components Tablet binders, disintegrants, coating agents, injectable vehicles NF / Ph. Eur.
Therapeutic Areas

Therapeutic Focus Areas

We supply intermediates across all major therapeutic categories, with deep experience in complex synthesis routes.

Cardiology Oncology Endocrinology Infectious Diseases Neurology Gastroenterology Respiratory Ophthalmology Dermatology Musculoskeletal
Market Drivers

Market Drivers & Government Support

  • check_circleProduction Linked Incentive (PLI) scheme for API manufacturing — ₹6,940 crore approved for 53 APIs
  • check_circle"Make in India" initiative reducing import dependence on Chinese API raw materials
  • check_circleGrowing global demand for generic drugs as branded patents expire
  • check_circleIncreasing contract manufacturing (CRO/CMO) partnerships with US and EU pharma companies
  • check_circleChina+1 diversification strategy driving international buyers toward Indian API sources
  • check_circleStrong domestic market: India supplies 60% of global vaccine demand and 20% of global generics
Quality & Compliance

Quality & Regulatory Standards

🏆

WHO-GMP Certified Supply

All manufacturers in our network hold current WHO-GMP certificates, reviewed annually. USFDA and EU-GMP approved facilities available on request.

📋

ICH Guidelines Compliance

ICH Q7 (API GMP), Q8 (pharmaceutical development), Q9 (quality risk management), and Q11 (development of drug substances) compliance across the supply chain.

🔬

CoA from NABL Labs

Certificates of Analysis issued by NABL-accredited laboratories with full method validation. HPLC purity reports, heavy metals, residual solvents, and endotoxin testing available.

Send an Enquiry

We respond within 24 hours.

Our Range

What We Supply

  • check_circleUSP / EP / BP grade chemicals
  • check_circleAPI synthesis intermediates
  • check_circleExcipients for solid dose manufacturing
  • check_circleCoA from NABL-accredited labs
  • check_circlecGMP-facility sourcing
  • check_circleHPLC purity reports on request